1.

MATTERS OF ADMINISTRATION

1.1

Welcome and apologies

1.2

Minutes and recommendations of the 168th MARC meeting

1.3

Declarations of potential conflicts of interest

2.

MEDSAFE PHARMACOVIGILANCE ACTIVITIES

2.1

Report on standing agenda items

2.2

Medsafe pharmacovigilance activities

2.3

Prescriber Update

2.4

Quarterly summary of recent safety communications

3.

PHARMACOVIGILANCE REPORTS

3.1

Matters referred to the MARC under section 36 of the Medicines Act 1981

3.2

Matters referred to the MARC by Medsafe

3.2.1

Concomitant use of opioids, benzodiazepines and other CNS depressants and the risk of serious side effects

3.2.2

Varicella vaccine: Overview of benefits and risks of harm

3.2.3

Use of anaesthetic and sedative agents in children - Neurotoxicity & effects on brain development

4.

MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE

4.1

CARM quarterly report

5.

OTHER BUSINESS

5.1

Therapeutic products regulation project - Update

5.2

Removing warnings of theoretical risks from data sheets - Discussion